Regenerative Treatment for Tympanic Membrane Perforation
Overview
Otorhinolaryngology
Affiliations
Objective: To establish a tissue engineering therapy for the treatment of large tympanic membrane perforation (TMP) without the need for conventional surgical therapy.
Study Design: Randomized control trial.
Setting: General hospital.
Patients And Methods: A total of 63 chronic TMPs were randomly selected from outpatients.
Intervention: Of the total 63 chronic TMPs, 53 were randomly assigned to the basic fibroblast growth factor (b-FGF) group and the remaining 10 were randomly assigned to the control group. Materials used for the TM repair were gelatin sponge and fibrin glue with/without b-FGF. After creating a mechanical disruption of the edge of the TMP, a gelatin sponge was immersed in b-FGF or saline (for the control group) and placed over the perforation. Fibrin glue was dripped over the sponge as a sealant.
Main Outcome Measures: The effectiveness of this therapy was evaluated by closure rates, hearing level, and sequelae 3 weeks after treatment. The treatment was repeated up to 4 times for cases in which complete closure of the TMP was not achieved after 1 round of treatment.
Results: Complete closure of the TMP was achieved in more than 98.1% (52/53) of the patients in the b-FGF group and 10% (1/10) of the patients in the control group. The average hearing level of all patients with successful TM repair was improved. Serious sequelae were not observed in any patient.
Conclusion: This study demonstrates that a combination of gelatin sponge, b-FGF, and fibrin glue enables the regeneration of the TM without conventional operative procedures. This innovative regenerative therapy is an easy, safe, cost-effective, and minimally invasive outpatient treatment.
Kurokawa S, Yagyuu T, Funayama N, Imada M, Kirita T Odontology. 2025; .
PMID: 39979497 DOI: 10.1007/s10266-025-01073-w.
Hyakusoku H, Aoyama J, Aoki T, Kamoshida R, Nakayama M Cureus. 2025; 16(12):e75259.
PMID: 39764322 PMC: 11701944. DOI: 10.7759/cureus.75259.
Bedir T, Baykara D, Yildirim R, Koyuncu A, Sahin A, Kaya E Nanomaterials (Basel). 2024; 14(7).
PMID: 38607098 PMC: 11013928. DOI: 10.3390/nano14070563.
Takizawa Y, Morino T, Takagi R, Otori N, Kojima H, Yamato M Regen Ther. 2024; 25:387-394.
PMID: 38425672 PMC: 10901693. DOI: 10.1016/j.reth.2024.02.001.
Benington L, Mo J, Li M, Rajan G, Locher C, Lim L Pharmaceuticals (Basel). 2024; 17(2).
PMID: 38399462 PMC: 10892888. DOI: 10.3390/ph17020247.